The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Screening and comorbidity of clinical levels of fear of cancer recurrence
Abstract
Purpose The prevalence of clinical levels of fear of cancer recurrence (FCR) in cancer survivors is unknown, which may be partly explained by the lack of an assessment method that would make it possible to distinguish between normal and clinical levels of FCR. Moreover, despite the apparent overlap between FCR and manifestations of some psychiatric disorders, no study has yet evaluated the comorbidity of clinical levels of FCR. The goals of this study were to assess the capacity of the Fear of Cancer Recurrence Inventory severity subscale, to consider a shorter form of the FCRI (FCRI-SF), to screen for clinical levels of FCR, and to assess its psychiatric comorbidity.Methods Sixty French-Canadian cancer survivors (73% of those eligible) who had been treated within the past 4 years for localized breast, prostate, lung, or colorectal cancer were randomly selected. Participants were administered a clinical interview assessing FCR, the Structured Clinical Interview for DSM-IV, and self-report scales.Results A cutoff score of 13 or higher on the FCRI-SF was associated with optimal sensitivity (88%) and specificity (75%) rates for the screening of clinical levels of FCR. Cancer survivors with clinical levels of FCR were significantly more likely to meet the criteria for a current psychiatric disorder (60%) than patients with nonclinical levels (29%). Anxiety disorders tended to be the most common comorbid disorders.Conclusions/implications for cancer survivors The FCRI-SF allows rapid and effective screening of clinical levels of FCR, a condition associated with significant psychiatric comorbidity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Left untreated, debilitating fears may linger throughout survivorship1,2 reducing quality of life (QoL).1,2,8,11,12”
From Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial. (2020) · cites this paper as [8]
In the citing paper
“Breast cancer survivors (BCS) are particularly vulnerable with up to 70% reporting clinically-significant FCR.”
From Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial. (2020) · cites this paper as [8]
In the citing paper
“All measures were validated, brief, and non-redundant, supporting parsimony while enabling comprehensive evaluation of intervention impact.”
In the citing paper
“On average, participants obtained a mean FCRI-T score of 68.9, and a score of 16.8 on the FCRI-S, which is above the clinical threshold (score of 13 or higher; 37).”
From Fear of cancer recurrence in breast cancer survivors carrying a BRCA1 or 2 genetic mutation : a cross-sectional study (2024) · cites this paper as [37]
In the citing paper
“clinical FCR is associated with impairment in functioning, psychological distress, sleep difficulties, stress response symptoms, and lower quality of life (QoL) [3–9].”
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Tabachnick, B. G., & Fidell, L. S. (1983) · Cited by 80,031
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
- STATISTICAL PACKAGE FOR SOCIAL SCIENCES
(2014) · Statistical Methods in Psychiatry Research and SPSS · doi:10.1201/b17560-26 · Cited by 12,056
Diagnostic and Statistical Manual of Mental Disorders(DSM)
(2008) · Encyclopedia of Counseling · doi:10.4135/9781412963978.n182 · Cited by 10,830
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Statistical Package for the Social Sciences
Greatorex, M. (2015) · Wiley Encyclopedia of Management · doi:10.1002/9781118785317.weom090665 · Cited by 4,389
The kappa statistic in reliability studies: use, interpretation, and sample size requirements
Sim, J., & Wright, C. C. (2005) · Physical Therapy · doi:10.1093/ptj/85.3.257 · Cited by 4,093
Research works printed but not linked: 1
- Fombonne E, Fuhrer R. L’application de l’analyse ROC en psychiatrie. Encéphale. 1995;18:545–50.
Cited by
Luigjes‐Huizer, Y. L., Tauber, N. M., Humphris, G., Kasparian, N. A., Lam, W. W. T., Lebel, S., Simard, S., Smith, A. B., Zachariae, R., Afiyanti, Y., et al. (2022) · Psycho-Oncology · doi:10.1002/pon.5921 · Cited by 332
“Other cancer types 115 (27) 43 (10) 138 (32) 133 (31) 111 (29) 55 (14) 100 (26) 114 (30)”
Self-citationSimonelli, L. E., Siegel, S. D., & Duffy, N. M. (2017) · Psycho-Oncology · doi:10.1002/pon.4168 · Cited by 292
“The nine-item FCRI severity subscale has demonstrated psychometric properties [7] and established sensitivity and specificity for a cutoff score of 13 [8].”
Butow, P. N., Turner, J., Gilchrist, J., Sharpe, L., Smith, A. B., Fardell, J. E., Tesson, S., O’Connell, R., Girgis, A., Gebski, V. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.1257 · Cited by 228
Vaz-Luis, I., Masiero, M., Cavaletti, G., Cervantes, A., Chlebowski, R. T., Curigliano, G., Felip, E., Ferreira, A. R., Ganz, P. A., Hegarty, J., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.07.1941 · Cited by 208
Lebel, S., Mutsaers, B., Tomei, C., Leclair, C. S., Jones, G., Petricone-Westwood, D., Rutkowski, N., Ta, V., Trudel, G., Laflamme, S. Z., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0234124 · Cited by 203
“Disease (k) Mode of determination (k) Range of prevalence Author Reported prevalence Determination of prevalence scores Cancer (58) 0–86 Cut-off (20) 4.3–70 Aghdam et al., 2014 [31] 49.6 Scale literature on FoP-Q-SF for “high FoP” Anderson et al., 2014 [134] 8 Scale literature cut-off for MAX-PC for “clinical fear of…”
BackgroundInfluential
Metadata
- Authors
- Simard, S., & Savard, J.
- Affiliations
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Université Laval (CA)
- Corresponding author
- Simard, Sébastien
- Venue
- Journal of Cancer Survivorship
- Published
- 2015-01-21
- Volume
- 9
- Issue
- 3
- Pages
- 481-491
- ISSN
- 1932-2259 (ISSN-L)
- 1932-2267
- OpenAlex
- W1991276220
- Cited by
- 329
- References
- 46
- Citations by year
- 2026: 24 · 2025: 45 · 2024: 41 · 2023: 38 · 2022: 43 · 2021: 31 · 2020: 18 · 2019: 33 · 2018: 17 · 2017: 18 · 2016: 14 · 2015: 6
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Cancer Survivorship (publishedVersion)
- PubMed (publishedVersion)
- Constellation (Université du Québec à Chicoutimi) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- fear of cancer recurrence, cancer survivors, screening cut-off values, psychiatric comorbidity, anxiety disorders, breast cancer, prostate cancer, lung cancer, colorectal cancer, psychological distress
- MeSH terms
- Fear, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasms, Comorbidity, Survivors, Disease Progression, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening and comorbidity of clinical levels of fear of cancer recurrence. https://app.cochat.ai/papers/10.1007/s11764-015-0424-4
- The paper
- Simard, S., & Savard, J. (2015). Screening and comorbidity of clinical levels of fear of cancer recurrence. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-015-0424-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.